(0.61%) 5 077.25 points
(0.37%) 38 209 points
(0.83%) 17 583 points
(0.68%) $79.54
(2.33%) $1.977
(0.18%) $2 315.20
(-0.25%) $26.68
(0.91%) $963.60
(0.09%) $0.934
(0.30%) $11.06
(0.01%) $0.799
(-1.42%) $91.94
Live Chart Being Loaded With Signals
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies...
Stats | |
---|---|
本日の出来高 | 876 000 |
平均出来高 | 2.38M |
時価総額 | 2.89B |
EPS | HKD0 ( 2024-03-28 ) |
次の収益日 | ( HKD0 ) 2024-05-28 |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 35.50 |
ATR14 | HKD0.0110 (0.78%) |
ボリューム 相関
Frontage Holdings Corp 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Frontage Holdings Corp 相関 - 通貨/商品
Frontage Holdings Corp 財務諸表
Annual | 2023 |
収益: | HKD259.86M |
総利益: | HKD78.39M (30.17 %) |
EPS: | HKD0.00530 |
FY | 2023 |
収益: | HKD259.86M |
総利益: | HKD78.39M (30.17 %) |
EPS: | HKD0.00530 |
FY | 2022 |
収益: | HKD250.36M |
総利益: | HKD89.19M (35.63 %) |
EPS: | HKD0.0126 |
FY | 2021 |
収益: | HKD184.44M |
総利益: | HKD66.70M (36.16 %) |
EPS: | HKD0.00900 |
Financial Reports:
No articles found.
Frontage Holdings Corp
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services that include study designs, execution of studies, and interpretation of the data through structural optimization in early discovery, pharmacokinetic studies in rodents, non- GLP bioanalytical studies, etc. The company also provides safety and toxicology services comprising in-vitro and in-vivo studies; bioequivalence services, which consist of designing, coordinating, and reporting of bioequivalence studies; chemistry services comprising contract research and custom synthesis services; and clinical services, such as early stage clinical, BE/BA, biometric, and data management services. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation is a subsidiary of Hongkong Tigermed Co., Limited.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。